Mutant SOD1 impairs axonal transport of choline acetyltransferase and acetylcholine release by sequestering KAP3 by Tateno, Minako et al.
Mutant SOD1 impairs axonal transport of choline
acetyltransferase and acetylcholine release by
sequestering KAP3
Minako Tateno1, Shinsuke Kato2, Takashi Sakurai3,{, Nobuyuki Nukina3, Ryosuke Takahashi4
and Toshiyuki Araki1, 
1Department of Peripheral Nervous System Research, National Institute of Neuroscience, National Center of
Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8502, Japan,
2Department of Neuropathology,
Institute of Neurological Sciences, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, Tottori 683-8504,
Japan,
3Laboratory for Structural Neuropathology, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako, Saitama 351-
0198, Japan and
4Department of Neurology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho,
Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
Received September 11, 2008; Revised and Accepted December 9, 2008
Mutations in the superoxide dismutase 1 (sod1) gene cause familial amyotrophic lateral sclerosis (FALS),
likely due to the toxic properties of misfolded mutant SOD1 protein. Here we demonstrated that, starting
from the pre-onset stage of FALS, misfolded SOD1 species associates speciﬁcally with kinesin-associated
protein 3 (KAP3) in the ventral white matter of SOD1
G93A-transgenic mouse spinal cord. KAP3 is a kinesin-
2 subunit responsible for binding to cargos including choline acetyltransferase (ChAT). Motor axons in
SOD1
G93A-Tg mice also showed a reduction in ChAT transport from the pre-onset stage. By employing a
novel FALS modeling system using NG108-15 cells, we showed that microtubule-dependent release of acetyl-
choline was signiﬁcantly impaired by misfolded SOD1 species. Furthermore, such impairment was able to be
normalized by KAP3 overexpression. KAP3 was incorporated into SOD1 aggregates in human FALS cases as
well. These results suggest that KAP3 sequestration by misfolded SOD1 species and the resultant inhibition
of ChAT transport play a role in the dysfunction of ALS.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a fatal, progressive neuro-
degenerative disease characterized by motor neuron cell death in
the brain and spinal cord accompanied by rapid loss of muscle
controlandeventuallycompleteparalysis(1,2).Thevastmajority
of ALS cases are of a sporadic nature, while 10% are familial
(FALS). Although the cause of sporadic ALS remains unclear,
15–20% of FALS patients have point mutations in cytosolic
Cu
2þ/Zn
2þ superoxide dismutase (SOD1). SOD1 is an antioxi-
dant enzyme ubiquitously expressed in the cytosol, which con-
verts the superoxide anion radical to hydrogen peroxide. More
than 115 disease-causing mutations, affecting all regions of the
SOD1 gene product, have been identiﬁed.
Previous studies using transgenic animal models expressing
mutated human SOD1 have shown that the disease is not caused
by a loss of its dismutase activity, but by the gain of toxic proper-
ties (1). Many mutant SOD1 proteins tend to become easily mis-
folded and form aggregates, especially under oxidative stress
(3,4). Intracellular aggregates containing SOD1 were speciﬁcally
detected in affected regions of both patients and animal models
possessing sod1 mutations (5–7). In spinal cords of mutant
SOD1-Tg mice, misfolded intermediates of mutant SOD1 pro-
teins, which showed a decrease in solubility and increase in
size, were found prior to disease onset (8,9). These results
suggest that misfolded molecules containing mutant SOD1 may
contribute to motor neuron-speciﬁc damage in ALS.
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Advance Access published on December 16, 2008Axonal transport is required for a variety of neural functions
including neurotransmitter synthesis, release and recycling
(10). Motor neurons often have long axons that can be more
than a meter in length in humans. For this reason, orderly
function of the axonal transport mechanism should be particu-
larly important in maintaining the structure and signal trans-
mission at the terminals of motor axons. The transport
process is carried out by two major families of motor proteins,
i.e. kinesin super family for anterograde transport and the
cytoplasimic dynein for retrograde transport (11). Defects in
axonal transport have been reported as an early sign of
motor neuron diseases including ALS (12). In mutant
SOD1-Tg mice, anterograde transport of neuroﬁlaments and
tubulin is partially impaired long before disease onset, pre-
sumably due to an inhibition of certain transport systems
(13,14). With respect to retrograde transport, mutations in
the dynein heavy chain result in motor-selective dysfunction
in mice (15). Moreover, mutation in p150
Glued, a subunit of
dynactin (dynein activator), was identiﬁed in a family that
developed a lower motor neuron-speciﬁc disease (16). These
results strongly suggest a link between the integrity of the
axonal transport mechanism with the function and survival
of motor neurons.
We previously studied the intracellular localization of mis-
folded SOD1 species by subcellular fractionation of spinal
cords from SOD1
G93A-Tg mice and found a signiﬁcant
accumulation of misfolded SOD1 species within the
axon-enriched fraction at disease onset (17). From this
result, together with previous reports, we hypothesized that
misfolded SOD1 species may bind to proteins required for
axonal transport and thereby inhibit normal function of the
motor proteins. To prove this hypothesis, we screened
axonal transport-related molecules in search for proteins that
associate speciﬁcally to the misfolded SOD1 species and
identiﬁed KAP3 as a misfolded SOD1-interacting protein.
KAP3 is a component of the kinesin-2 motor complex mediat-
ing an axonal transport of choline acetyltransferase (ChAT) in
Drosophila (18,19). By using an in vitro FALS modeling
system that we developed, we showed that misfolded SOD1
inhibits axonal transport-dependent release of acetylcholine
(ACh). Moreover, such impairment of ACh release could be
rescued by the KAP3 overexpression. This evidence strongly
suggests that the sequestering of KAP3 and the resultant inhi-
bition of ChAT transport is a novel toxic property of mutant
SOD1 proteins that inevitably leads to motor neuron-speciﬁc
dysfunction.
RESULTS
Misfolded SOD1 species is accumulated in ventral white
matter of spinal cords in SOD1
G93A-Tg mice prior to
disease onset
We previously showed by using subcellular fractionation
analysis that a considerable amount of misfolded SOD1
species is located in a fraction enriched in nucleus and
certain kinds of cytoskeletal proteins (i.e. glial ﬁbrilary
acidic protein and neuroﬁlament) in SOD1
G93A-Tg mice
spinal cord prior to appearance of characteristic motor
symptoms of ALS (17). To analyze more detailed subcellular
localization of misfolded SOD1 in spinal motor neurons of
SOD1
G93A-Tg mice, we divided the spinal cord into four sub-
segments by laser-assisted microdissection (LMD) (summar-
ized in Fig. 1A) and used the lysate from each segment to
detect SOD1 by immunoblot analysis. Since we observed that
the SOD1
G93A-Tg mice we used in this study experienced
disease onset around the age of 8 months (246.5+5.8 days)
and died around 9.5 months (288.5+7.1 days, mean+
SEM, n ¼ 14), we chose to collect samples from mice of 4,
7, 8 and 9 months of age. As expected, the majority of mis-
folded SOD1 species (high molecular-weight bands/smears
immunoreactive for SOD1) was located in the ventral gray
matter at 7 months of age, which is 1 month prior to disease
onset (Fig. 1B and C). At this age, we also found that a signiﬁ-
cant amount of misfolded SOD1 species was located in ventral
white matter, suggesting that misfolded SOD1 species are
localized in motor neuron cell bodies and their axons. We
further divided the ventral white matter segment into three
subsegments and conﬁrmed a localization of misfolded
SOD1 species to a motor axon-enriched segment indicated
by ChAT expression (Supplementary Material, Fig. S1).
Together, these results suggest that a signiﬁcant amount of
misfolded SOD1 species is located not only in motor neuron
cell bodies, but also in motor axons of SOD1
G93A-Tg mice
prior to disease onset.
Misfolded SOD1 species associates with KAP3,
a kinesin-2 component
Previous reports strongly suggest that impairment of the
axonal transport mechanism is linked to degeneration of
motor neurons (12). Localization of misfolded SOD1 species
in motor axons of SOD1
G93A-Tg mice suggests that misfolded
SOD1 species may affect the function of proteins required for
axonal transport. Anterograde and retrograde axonal transports
are mediated by different protein complexes, which are com-
posed of a large variety of proteins. The kinesin super
family for anterograde transport, for instance, is divided into
six families (kinesin-1, 2, 3, 4, 13 and 14) consisting of 45
members in human and mouse, and they associate with appro-
priate cargos via adaptor molecules in most cases (11). To gain
more insight into the relationship between misfolded SOD1
and individual components of the molecular motor protein
complex, we compared sedimentation of misfolded SOD1 in
linear density gradient centrifugation with that of representa-
tive molecules that compose motor complexes in motor
axon lysate. We asked whether any of these motor complex
components co-migrate with misfolded SOD1. Homogenates
were prepared from the ventral white matter of SOD1
G93A-Tg
mice at 8 months of age (disease onset) and SOD1
WT-Tg
mice expressing human wild-type sod1 gene (non-symptomatic
control) and subjected to linear Nycodenz density gradient
centrifugation. SOD1 immunoreactive bands showing expected
molecular weight (representing normally folded SOD1) were
observed in fractions nos 1–7 in mice of both genotypes. Mis-
folded SOD1 species, on the other hand, were found in frac-
tions around no. 16 only in SOD1
G93A-Tg mice. We then
examined migration proﬁles of 17 major components of the
molecular motors from ﬁve kinesin families excluding
kinesin-4 which is mostly expressed in juvenile brain,
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KAP3, a subunit of the kinesin-2 motor complex, clearly
co-migrated with misfolded SOD1 species around fraction
no. 16 from SOD1
G93A-Tg mice (Fig. 2A, asterisks). In
addition to KAP3, KIF3A and KIF3B, which are KAP3-
binding partners, were weakly detected around fraction no.
16. We also observed p150
Glued, a dynactin subunit,
co-migrated with misfolded SOD1 species. However, we did
not proceed to a detailed analysis of this observation for
now, because p50, another dynactin subunit (data not
shown), or other dynein components such as Dynein inter-
mediate chain (Dynein IC in Fig. 2A) did not co-migrate
with misfolded SOD1 species. To conﬁrm this association of
KAP3 with misfolded SOD1, we performed immunoprecipita-
tion analysis using the fraction nos 16 and 7. KAP3 was identi-
ﬁed in anti-SOD1 immunoprecipitates obtained from fraction
no. 16 containing misfolded SOD1 species but not in the frac-
tion from no. 7 (Fig. 2B). In reciprocal immunoprecipitation,
we found misfolded SOD1 in anti-KAP3 immunoprecipitates
only in fraction no. 16. CRMP-2 (collapsin response mediator
protein-2), a KAP3 counterpart for kinesin-1 motor complex,
did not associate with misfolded SOD1. KAP3 seems to be
associated with misfolded SOD1 species at least 2 months
before disease onset, since the misfolded SOD1 species was
detected in the immunoprecipitate with anti-KAP3 antibody
from the extracts of 6-month-old SOD1
G93A-Tg spinal cords
(Fig. 2C). Furthermore, we examined immunohistochemical
localization of SOD1 and KAP3 on spinal cord sections of
SOD1
G93A-Tg mice at 9 months of age (end stage). We
found that protein aggregates in the remaining spinal motor
neurons, immunoreactive for KAP3 were also positive for
SOD1 (Fig. 2D, upper panel). The KAP3-positive aggregates
also contained ubiquitin immunoreactivity, suggesting that
the aggregates are cellular inclusion bodies (Fig. 2D, lower
panel). These results suggest that misfolded SOD1 species
speciﬁcally binds to KAP3 in motor axons of SOD1
G93A-Tg
mice and that this association starts prior to the onset of
motor symptoms.
Axonal transport of ChAT was signiﬁcantly impaired
in spinal motor neurons preceding disease
onset in SOD1
G93A-Tg mice
Kinesin-2 is a ubiquitously and abundantly expressed molecu-
lar motor complex, which consists of KAP3 and KIF3A,
together with either KIF3B or KIF3C (20). The motor
domain consisting of KIF3A along with either KIF3B or
KIF3C translocates along microtubules with hydrolyzing
ATP, and KAP3 determines the speciﬁc cargo to be trans-
ported. Recent work using Drosophila ganglionic cells
showed that kinesin-2 is involved in the transport of ChAT
and ACh esterase (AChE) (18). Although both of the
enzymes are essential for an efﬁcient supply of ACh to the
nerve terminals of spinal motor neurons, the amount of
Figure 1. Misfolded SOD1 species were enriched in ventral white matter and ventral gray matter in spinal cord of SOD1
G93A-Tg mice prior to disease onset. (A)
The procedure to divide and obtain subsegments of spinal cord is schematically shown. Unﬁxed frozen sections from L5 spinal cords were stained with 0.01%
Toluidine blue and cut into four segments: dorsal white matter (WM-D), dorsal gray matter (GM-D), ventral white matter (WM-V) and ventral gray matter
(GM-V) as indicated. (B) The presence of misfolded SOD1 species in the spinal cord subsegments obtained from 4, 7, 8 and 9.5 months old SOD1
G93A-Tg
mice and 8 months old wild-type control (non-Tg) mice by immunoblot analysis is shown. Identity of the sample in each lane is indicated above the image.
High molecular-weight bands/smears immunoreactive for SOD1 are the misfolded SOD1 species indicated by an asterisk. This misfolded SOD1 species
appeared both in WM-V and GM-V of SOD1
G93A-Tg mice at 7 months. The same blot was analyzed for expression of ChAT (a motor neuron marker), neuroﬁla-
ment M (NF-M; a neuronal marker), MBP (a myelin marker) for controls. Actin served as a loading control. (C) The immunoreactivity of both monomeric
(normally folded) and misfolded SOD1 that is shown in immunoblot analysis in (B) was quantiﬁed. The expression level of total SOD1 as well as monomeric
and misfolded SOD1, in arbitrary units relative to actin expression is shown as a bar graph.
944 Human Molecular Genetics, 2009, Vol. 18, No. 5Figure 2. Misfolded SOD1 species in ventral white matter of spinal cords speciﬁcally associates with KAP3. (A) Fractions obtained from Nycodenz density gradient
centrifugation of ventral white matter of 8-month-old SOD1
WT-Tg and SOD1
G93A-Tg spinal cords were analyzed for the presence of indicated proteins (SOD1 and indi-
vidual components of kinesin and dynein motor complexes) by immunoblot analysis. Each lane (left to right) represents an aliquot collected from the top. Note that mis-
folded SOD1 species (indicated by asterisks) migrated around fraction no. 16 in SOD1
G93A-Tg spinal cords, where KAP3 co-migrated. (B) Immunoprecipitates
of anti-SOD1 and KAP3 antibodies (indicated as ‘IP:SOD1’ or ‘IP:KAP3’) from Nycodenz density gradient centrifugation fractions 7 and 16 (F7, F16) of
SOD1
G93A-Tg mouse spinal cords prepared above were analyzed for the presence of indicated proteins by immunoblot analysis. Also shown is an immunoblot of
samplesF7andF16(20%oftheamountusedforimmunoprecipitation)examinedforexpressionofthesamesetofproteins.NotethatmisfoldedSOD1–KAP3association
wasdetectedfromF16butnotfromF7.(C)Immunoprecipitatesofanti-KAP3antibodyfromwholespinalcordextractsof4-,6-and8-month-oldSOD1
G93A-Tgmiceand
8-month-oldSOD1
WT-TgmicewereanalyzedforthepresenceofmisfoldedSOD1byimmunoblot.KIF3AandKIF3B,whicharekinesin-2components,servedascontrols
for immunoprecipitation. Note that misfolded SOD1 species (asterisks) were captured by anti-KAP3 antibody in 6-and 8-month-old SOD1
G93A-Tg extracts. (D)R e p r e -
sentativephotographsof immunohistochemicalco-localizationof KAP3andSOD1(upperpanel),andKAP3andubiquitin(lower panel)ina 9-month-oldSOD1
G93A-Tg
mouse spinal cord. Insets show higher magniﬁcation images of boxed area. Arrowheads indicate aggregate-like structures within motor neuron cell bodies, which were
positive for both KAP3 and SOD1 (upper panel) and KAP3 and ubiquitin (lower panel). Scale bars¼50 mm.
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ACh (21). Therefore, to examine the impact of misfolded
SOD1–KAP3 association on the function of motor neurons
in SOD1
G93A-Tg mice during the disease progression, we
decided to analyze the transport of ChAT in motor neurons.
To achieve this, we obtained motor–cargo protein complexes
using a previously described method from ventral roots of the
caudal spinal cord, which represent motor axons just extended
from the spinal cords and examined the presence of ChAT
by immunoblot analysis. We found that a signiﬁcantly
lower level of ChAT was present in cauda equina of
SOD1
G93A-Tg mice compared with those of SOD1
WT-Tg at
7 months of age or later (Fig. 3A). Furthermore, kinesin-2
motor components, KAP3, KIF3A and KIF3B, all showed a
similar decrease in expression during the disease progression
in cauda equina of SOD1
G93A-Tg mice. On the other hand,
KHC (kinesin heavy chain), KLC (kinesin light chain)
(kinesin-1 components) and Rab3 (a synaptic vesicle-associated
protein transported by KIF1A) were consistently expressed
during the disease progression. Decreased ChAT transport in
pre-symptomatic SOD1
G93A-Tg mouse sciatic nerve was also
demonstrated by a ligation assay (Supplementary Material,
Fig. S2A). These results suggest that the amount of ChAT
transported by the kinesin-2 complex signiﬁcantly decreases in
motor axons of SOD1
G93A-Tg mice prior to disease onset.
The results presented in Figure 2A show that ChAT does
not co-migrate with the misfolded SOD1–KAP3 complex,
suggesting that KAP3 does not bind to ChAT and misfolded
SOD1 at the same time. Decreased amounts of ChAT and
kinesin-2 motor complex within the axons of motor neurons
in SOD1
G93A-Tg mice, together with Figure 2A data, suggest
that the misfolded SOD1 species may inhibit kinesin-2-
mediated ChAT transportation by trapping the kinesin-2
motor complex in the motor neuron cell body and the sur-
rounding areas. For a better understanding of the misfolded
SOD1 species behavior in motor axons of SOD1
G93A-Tg
mice, we compared the migration proﬁle in a sucrose
density gradient centrifugation of kinesin motor components
and ChAT with that of SOD1, by using the axonal motor-
cargo protein complexes prepared above as a sample. We
found that a small amount of misfolded SOD1 species are
present in axonal motor–cargo protein complexes and
co-migrate with a small fraction of KAP3, KIF3A (Fig. 3B)
and KIF3B, although the detection of KIF3B requires very
long exposure (data not shown). We also found that ChAT
co-immunoprecipitates with KAP3 in fractions where KAP3
and kinesin-2 components co-migrated. (Supplementary
Material, Fig. S2B). These results suggest that misfolded
SOD1 species not only trap the kinesin-2 motor complex via
association with KAP3 in and around the cell bodies but
some of the misfolded SOD1 is also transported to axons in
stead of normal cargos such as ChAT.
NG108-15 cells serve as an in vitro model for FALS
We showed a clear correlation between the association of mis-
folded SOD1 with KAP3 and the inhibition of ChAT transport
within SOD1
G93A-Tg mouse motor axons. To examine the
causal relationship between these two phenomena in detail,
we developed a novel cell culture model for FALS, in which
cells show cholinergic neuron-like properties—ChAT is trans-
ported within axon-like processes, ACh is released by depolar-
ization and mutant SOD1 is misfolded/aggregated. For this
purpose, we employed NG108-15 cells, which are of neuron/
glia origin and known to differentiate into a cholinergic
neuron-like phenotype (22,23). We ﬁrst cloned a single cell-
derived subline of NG108-15 cells, which we termed PNG3
(Puriﬁed NG108-15 cell-3), that showed highest expression
of ChAT upon differentiation with dibutyryl cAMP and dexa-
methasone (data not shown). We observed that expression of
ChAT and synaptophysin (an integral membrane protein
found on synaptic vesicles) reaches the maximal level at
72 h after the stimulation (Fig. 4A). By immunocytochem-
istry, we found that expression of ChAT and KAP3 were pre-
dominantly detected within the extended PNG3 processes in
72 h after the stimulation (Fig. 4B) as other kinesin-2 subunits
(data not shown). From these observations, we decided to use
PNG3 cells as a model for cholinergic neurons at day 3 after
initiating differentiation for all the following experiments.
InordertousePNG3cellsasacelllinemodelforFALS,mis-
folding/aggregate formation by mutant SOD1 overexpression
needs to be observed. Oxidative stress tends to cause mutant
SOD1 proteins misfold and form aggregates (4). Experimen-
tally, mutant SOD1 aggregate formation can be observed
and facilitated by inhibiting proteasomal activity (24,25).
Figure 3. Axonal transport of ChAT was selectively impaired in spinal motor
neurons preceding disease onset in SOD1
G93A-Tg mice. (A) Axonal transport
components obtained from ventral roots from caudal spinal cords of
SOD1
WT-Tg and SOD1
G93A-Tg mice at indicated ages were analyzed for the
presence of indicated proteins by immunoblot analysis (left panel). The
expression level of each molecule examined for SOD1
G93A-Tg mice is
shown as a percentage of the level at 4 months of age (right panel). Note
that the decrease in detection levels of ChAT and kinesin-2 components
(KAP3, KIF3A and KIF3B) in SOD1
G93A-Tg mice became apparent at 7
months of age, 1 month before disease onset. (B) Fractions obtained from a
sucrose density gradient centrifugation of axonal transported components
from 8-month-old mice were analyzed for the presence of indicated proteins
(SOD1 and individual components of kinesin motor complexes) by immuno-
blot analysis. Each lane (left to right) represents an aliquot collected from the
top. Note that only kinesin-2 components co-migrated with misfolded SOD1
species (indicated by asterisks on the blots).
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stress plus decreased proteasomal activity to induce SOD1 mis-
folding and to enhance an accumulation of those misfolded
SOD1 species in differentiated PNG3 cells overexpressing
mutantSOD1.WetransfectedPNG3cellswithpreviouslywell-
studied G93A, G85R and A4V mutations and wild-type control
of human SOD1 for overexpression (3). Misfolded SOD1
species was detected in1% Triton X-100 insoluble fractions of
lysates derived from all three types of FALS-linked SOD1
mutant transfectants but not in wild-type SOD1-overexpressing
cells (Fig. 4C). We also found that SOD1 protein bearing the
G85R mutation became misfolded without increasingoxidative
stress, showing the previously reported unstable nature of
this mutant protein (24). These results suggest that mutant
SOD1 can form misfolded and/or aggregated molecules in
differentiated PNG3 cells, very similar to what is seen in
SOD1
G93A-Tg mice by pathological stresses.
For the analysis of pathological signiﬁcance of misfolded
SOD1–KAP3 association in this PNG3 cell model system,
we next asked whether association of KAP3 with misfolded
SOD1 is observed in this model just as we saw in the
SOD1
G93A-Tg mice. To prove the association of KAP3 with
misfolded SOD1 directly, we performed immunoprecipitation
experiments using lysates of PNG3 cells transfected with
either wild-type or mutant SOD1, and then treated with
hydrogen peroxide to induce the mutant SOD1 misfolding.
We found that anti-KAP3 immunoprecipitates contained mis-
folded SOD1 species, and the antibody against mutant
SOD1-Flag immunoprecipitated misfolded SOD1 together with
KAP3 (Fig. 5A). To visualize the misfolded SOD1-KAP3
association in PNG3 cells, we performed immunocytochemical
analysis for localization of KAP3 and mutant SOD1. We
found mutant SOD1-immunoreactive aggregates were prominent
in cell bodies as well as the processes of MG132-treated differ-
entiated PNG3 cells expressing G85R SOD1, and those aggre-
gates were also positive for KAP3 (Fig. 5B and C). These
observations together suggest that the cellular FALS model
that we developed here using PNG3 cells recapitulates
the association of KAP3 and misfolded SOD1 observed in
SOD1
G93A-Tg mice and therefore is suitable to analyze the
pathological impact of the misfolded SOD1-KAP3 association
on motor neurons.
Microtubule-dependent fraction of depolarization-induced
ACh release from PNG3 cells requires KAP3
In Drosophila neurons, the kinesin-2 motor complex is respon-
sible for anterograde axonal transport of ChAT (18,19). To
examine whether the same is true in mammals, we ﬁrst devel-
oped an assay model to detect a depolarization-induced
microtubule-dependent release of ACh as a result of ChAT
transport. Differentiated PNG3 cells were metabolically
Figure 4. PNG3 cells served as an in vitro model system for studying mutant SOD1 toxicity on cholinergic neurons. (A) Expression of indicated proteins in
PNG3 cells during cholinergic neuron-like differentiation was examined by immunoblot analysis. PNG3 cells were lysed at indicated times after induction
of differentiation by dibutyryl cAMP and dexamethasone. Representative images of immunoblots (left panel) and quantitative analysis of the blots (right
panel) are shown. Expression level is normalized to actin and relative to the level of normal spinal cord at each time point for each molecule. (B) Representative
photographs of ChAT and KAP3 expression in differentiated PNG3 cell bodies and processes detected by immunocytochemistry are shown. Scale bar¼25 mm.
(C) Generation of misfolded SOD1 species in PNG3 cells overexpressing FLAG-tagged SOD1 bearing WT, G93A, G85R or A4V mutation was evaluated by
immunoblot analysis. The transfected PNG3 cells were either untreated, treated by MG132 or treated by MG132 followed by H2O2 (as indicated above the
images). One perecnt Triton X-100-soluble and -insoluble fractions were separately analyzed for SOD1-FLAG, KAP3, KHC and actin (for loading control).
Spinal cords of 2- and 9-month-old SOD1
G93A-Tg mice were also subjected for the same set of analysis for comparison.
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3H]choline, and depolarization-induced [
3H]
ACh release was measured. We observed that PNG3 cells
released [
3H]ACh in a KCl dose-dependent manner
(Fig. 6A). To distinguish ‘nerve terminal’ ACh release from
exocytosis at other locations, we examined ACh release with
and without colchicine, a microtubule destabilizing reagent
that inhibits axonal transport (18). From ACh release exper-
iments with different trial amounts of colchicine, we decided
to use colchicine at 2.5 mM for the best differentiation of
microtubule-dependent release representing the release from
the terminal of differentiated PNG3 cellular processes. Treat-
ing the cells with this concentration converted nearly 20% of
the tubulin from ﬁlamentous to free form in PNG3 cells (Sup-
plementary Material, Fig. S3A). Then to analyze the involve-
ment of KAP3/kinesin-2 in ChAT transport in the mammalian
neuron using this assay system, we examined the effect of
KAP3 mRNA down-regulation in differentiated PNG3 cells.
Although NG108-15 cells are mouse–rat hybrid, transfection
of siRNA for mouse KAP3 in PNG3 cells decreased the
KAP3 protein level to 15% after 2 days (Supplementary
Material, Fig. S3B). We found that siRNA-mediated down-
regulation of KAP3 signiﬁcantly reduced the microtubule-
dependent fraction of ACh release from PNG3 cells
(Fig. 6B). This reduction in ACh release was rescued by the
co-transfection of full-length human KAP3 which is not
affected by the mouse siRNA we used. However, the ACh
release was not rescued by the human KAP3 lacking C-
terminal sequence (513–792 amino acids), which is required
for the interaction with KIF3A/B (26). These results suggest
that KAP3 is required for ChAT transport along microtubules
and the subsequent release of ACh from nerve terminals in
mammalian neurons.
As described above, we observed decreased ChAT axonal
transport in SOD1
G93A-Tg mice. To examine whether mis-
folded SOD1 inhibits ChAT transport also in this FALS
model system in culture, we measured microtubule-dependent
ACh release from differentiated PNG3 cells after induced pro-
duction of misfolded SOD1 species (procedure is summarized
in Fig. 6C). We found that induction of SOD1 misfolding by
MG132 treatment resulted in a signiﬁcant decrease of micro-
tubule-dependent ACh release from mutant SOD1-expressing
PNG3, but not from wild-type SOD1-expressing cells
Figure 5. KAP3 associates with misfolded SOD1 species in differentiated PNG3 cells. (A) Immunoprecipitates of anti-FLAG and KAP3 antibodies (labeled as
‘IP:FLAG’ or ‘IP:KAP3’) from lysates of PNG3 cells transfected with expression plasmids for wild-type SOD1 or SOD1 with G93A, G85R or A4V mutation
with or without induction of misfolding by MG132/H2O2 were analyzed for the presence of indicated proteins by immunoblot analysis. Immunoblot of lysates
used for immunoprecipitation (20% of the amount) of the expression of the same set of proteins is also shown. Note that misfolded SOD1–KAP3 association was
detected in all three mutant SOD1 transfectants (indicated by asterisks). (B and C) Photographs of KAP3 and FLAG-tagged SOD1 in differentiated PNG3 cells
transfected with either FLAG-tagged wild-type SOD1 or SOD1 bearing a G85R mutation before and after MG132 treatment are shown in (B) and (C), respect-
ively. Phase contrast images are also shown to the right of each set. Asterisks indicate untransfected cells. Note that prominent aggregate formation is only in the
mutant SOD1-expressing cells and processes after MG132 treatment. Scale bars¼25 mm.
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regulation of both microtubule-dependent and -independent
ACh release (Fig. 6D and Supplementary Material,
Fig. S4A). However, this MG132-induced increase in ACh
release was presumably caused by increased expression
levels of proteins necessary for ACh synthesis/release and
was independent from the misfolded SOD1-induced effect
(Supplementary Material, Figs S4B and C). These results
suggest that misfolded SOD1 inhibits ChAT transport in this
FALS model system in culture as well.
The observations in SOD1
G93A-Tg mice, as well as in the
cellular FALS model system that we described, further
Figure 6. Microtubule-dependent fraction of depolarization-induced ACh release from PNG3 cells requires KAP3. (A) Differentiated PNG3 cells, metabolically
labeled with [
3H]choline, were depolarized by increased KCl in the medium for 15 min. The radioactivity was released into the medium representing [
3H]ACh
and was measured for different concentrations of KCl and colchicine, as indicated. (B) Depolarization-induced [
3H]ACh release from differentiated PNG3 cells
transfected with vector only, siRNA for mouse KAP3 (mKAP3) or siRNA for mKAP3 together with expression plasmid for either human KAP3 (hKAP3) or
hKAP3 lacking C-terminal 223 amino acids (DhKAP3), expression plasmid for hKAP3 only or expression plasmid for DhKAP3 was determined with or without
colchicine treatment. Radioactivity is shown as a percentage to that from vector-transfected, colchicine-untreated cells. The asterisk indicates non-signiﬁcant
differences calculated as P . 0.05. Note that KAP3 down-regulation inhibited microtubule-dependent ACh release. (C) Summarized time schedule for
[
3H]ACh-release measurement in differentiated PNG3 cells with and without SOD1 misfolding/aggregation. KCl-evoked release of ACh was calculated by sub-
tracting the radioactivity in S1 (medium before KCl addition) from that in S2 (medium after KCl addition). (D) Depolarization-induced [
3H]ACh release from
differentiated PNG3 cells transfected with vector only, expression plasmid for wild-type SOD1 or G85RSOD1 was determined with or without MG132 treat-
ment. Microtubule-dependent and -independent fractions of release were measured for each condition analyzed. Radioactivity is shown as percentage to that
from vector-transfected, colchicine-untreated cells. Note that ACh release from mutant SOD1-transfected cells was reduced in response to MG132 treatment,
while overexpression of mutant SOD1 per se did not affect choline incorporation into cells (Supplementary Material, Fig. S4C). The asterisk indicates non-
signiﬁcant difference calculated as P . 0.05. (E) Depolarization-induced [
3H]ACh release from differentiated PNG3 cells transfected with vector only,
expression plasmid for wild-type SOD1 or G85RSOD1, with or without co-transfection of mKAP3 expression plasmid, was determined after MG132 treatment.
Microtubule-dependent and -independent fractions of release were measured for each condition analyzed. Radioactivity is shown as a percentage of that from
vector-transfected, colchicine-untreated cells. Note that the reduction in ACh release observed in mutant SOD1-transfected cells in response to MG132 treatment
was normalized by mKAP3 expression. The asterisk indicates non-signiﬁcant difference calculated as P . 0.05.
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of the functional kinesin-2 complex via its association with
KAP3. This raises the possibility that misfolded
SOD1-induced reduction in ChAT transport may be normal-
ized by supplementing motor neurons with KAP3. To prove
this hypothesis using the FALS culture model system, we
examined microtubule-dependent ACh release from differen-
tiated PNG3 cells overexpressing wild-type or mutant SOD1
together with KAP3. Overexpression of KAP3 did not
change ACh release from MG132-treated PNG cells trans-
fected with empty vector or wild-type SOD1. However, over-
expression of KAP3 was able to normalize the ACh release
reduction under the condition that causes mutant SOD1 mis-
folding (Fig. 6E). These results strongly suggest that mis-
folded SOD1-induced reduction in ChAT transport and ACh
release is mediated by a reduction in functional KAP3 mol-
ecule because of its association with misfolded SOD1. These
results may also suggest that the normalization of functional
KAP3 level in motor neurons could have a therapeutic effect
on FALS pathogenesis.
KAP3 was co-localized with mutant SOD1 aggregates
within LBHI in spinal motor neurons from human FALS
patients
As described, we performed analysis of the misfolded
SOD1-induced reduction of ChAT transport in cultured cells
in cultured cells as well as in a mouse model. To gain
insight into the signiﬁcance of this mechanism in human
FALS, we performed immunohistochemistry on spinal cord
sections of human SOD1-linked FALS cases to examine
co-localization of KAP3 and SOD1. The neuropathological
phenotypes of four patients we analyzed, who were
members of two different families (27–29), are summarized
in a table in Figure 7. These patients often developed
Lewy-body-like hyaline inclusions (LBHIs), which are
protein aggregates containing mutant/wild-type SOD1 and
one of the most characteristic cytopathological changes in
the spinal motor neurons of mutant sod1-linked FALS (28).
Immunohistochemical analysis revealed that most of the
LBHIs in the spinal motor neurons were positive for both
KAP3 and SOD1 (arrowheads in Fig. 7). We conﬁrmed that
the KAP3 signal in LBHIs was not present when the
anti-KAP3 antibody was pre-incubated with an excess of the
synthetic KAP3 antigen peptides (data not shown). These
observations demonstrated that KAP3–SOD1 interaction and
subsequent co-aggregation frequently occurs in human
SOD1-linked FALS cases.
DISCUSSION
In this paper, we presented a novel pathological mechanism by
which misfolded SOD1 may cause neuronal dysfunction in
FALS. A signiﬁcant proportion of misfolded SOD1 is
located within motor axons prior to disease onset in
SOD1
G93A-Tg FALS model mice. We showed that misfolded
SOD1 species selectively binds to KAP3 (Fig. 2B and C)
and that this binding may be a cause for the reduction in
functional KAP3 molecule required for kinesin-2-dependent
transport within motor axons (Fig. 3A and B). The kinesin-2
motor complex is particularly important, because it is required
for ChAT transport (19). Decreased ChAT expression
and resultant decrease in ACh release from motor nerve
ends can lead to dysfunction of motor synapses at axon term-
inals (30,31). By employing a newly developed cell culture
model of FALS, we showed that ACh release from nerve
terminals was decreased presumably due to a reduction in
ChAT transport resulting from KAP3 sequestration by mis-
folded SOD1 species (Figs 5A and C and 6D). The pathologi-
cal mechanism we propose from our data is schematized
in Figure 8.
ALS-like motor neuron pathology is observed in transgenic
mice expressing C-terminal truncated SOD1 (L126Z), in
which the mutant SOD1 expression was not clearly observed
in sciatic nerve (32). This suggests that KAP3-misfolded
SOD1 association is formed mostly in motor neuron cell
bodies. Indeed, we detected KAP3-misfolded SOD1 associ-
Figure 7. KAP3 was co-localized with SOD1 aggregates within LBHI in
spinal motor neurons from human FALS cases. Consecutive sections of LBHI-
containing spinal motor neurons from FALS patients possessing sod1
mutations were immunostained with anti-KAP3 and anti-SOD1 antibodies.
The clinicopathological characteristics of the FALS patients are summarized
in the table. D125X mutation is a deletion of two nucleotides at codon 126
that results in the truncation of ﬁve residues downstream. Co-localization of
KAP3 and SOD1 within the LBHI is evident (arrowheads). The images are
representative of 30 LBHIs observed in each case, all of which showed
co-localization of SOD1 and KAP3. Scale bars¼25 mm for the images of
top row, 50 mm in others.
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(Fig. 2A and B) of SOD1
G93A-Tg mice prior to disease
onset, but could not detect it in distal sciatic nerve even at
the end-stage (data not shown). These ﬁndings suggest that,
even if misfolded SOD1 associates with molecular motors, it
cannot travel for a long distance, presumably because it is
not a physiological cargo.
We suspect that misfolded SOD1–KAP3 association is one
of the early events in FALS pathogenesis. Evidence to support
this possibility is that the SOD1–KAP3 association becomes
detectable around 6 months of age in SOD1
G93A-Tg mice, 2
months earlier than disease onset (Fig. 2C), suggesting
that the SOD1–KAP3 association constitutes an early event
in FALS motor neurons. Also, our immunoprecipitation/
immunoblot analysis shows that SOD1–KAP3 association
always detected relatively low molecular-weight misfolded
SOD1 (250 kDa) among all of the misfolded products
ranging up to hundreds of kilodaltons in size (Figs 2B and C
and 5A). The preferential association of KAP3 for low
molecular-weight species but not with large precipitates
suggests that SOD1–KAP3 association accounts for a fraction
of the initial events in FALS pathogenesis. Previous reports
on selective increase in KAP3 transcription in lumbar spinal
cords from SOD1
G86R-Tg mice as an early event prior to
disease onset (33) also supports our hypothesis, as the increase
maybe regarded ascompensatory tothe KAP3 sequestrationby
SOD1–KAP3 association.
Previous reports show that crossing mutant SOD1-Tg mice
with dynein heavy chain mutant mice (loa or cra) delays the
disease onset and extends survival (34,35). This result is sur-
prising because mutations in dynein heavy chain, a subunit
of dynein motor complex, or p150
Glued, a subunit of dynactin
(dynein activator) cause dysfunction and degeneration of
spinal motor neurons (15,16). This suggests a possible
mechanistic link between impaired axonal transport in
mutant SOD1-Tg mice and that in dynein heavy chain
mutant mice. Here we demonstrated that KAP3 sequestration
by misfolded SOD1 is a mechanism for selective inhibition
of axonal transport observed in mutant SOD1-Tg mice. Pre-
vious reports on melanophore transport in Xenopus melano-
somes showed that dynactin serves as an activator of
kinesin-2 via direct binding of p150
Glued to KAP3 and regu-
lates the intracellular direction of melanosome transport by
binding to either dynein (retrograde) or KAP3 (anterograde)
(36). Dynein and KAP3 share the same binding site on
p150
Glued, and so p150
Glued binds to only one of them at a
time and thereby activates transport in only one direction. If
a similar regulation by dynactin plays a role in mammalian
neurons, loa and cra mutations may increase the chance of
p150
Glued to bind to KAP3, because those mutations
promote subunit disassembly and increase dynein-unbound
dynactin (15). By this mechanism, dynein heavy chain
mutations may result in normalizing kinesin-2-mediated trans-
port of ChAT inhibited by the misfolded SOD1 species.
Indeed, in our analysis of ventral white matter in
SOD1
G93A-Tg mice using Nycodenz density gradient centrifu-
gation, a small fraction of p150
Glued co-migrated with mis-
folded SOD1 species and KAP3 (Fig. 2A). This population
of p150
Glued also co-precipitated with KAP3 (data not
shown). This result may reﬂect an involvement of p150
Glued
in KAP3/SOD1 misfolding and aggregation through its inter-
action with KAP3.
Figure 8. A schematic diagram for a mutant SOD1 toxicity and impairment of axonal transport of ChAT. In healthy motor neurons (A), ChAT is continuously
transported by kinesin-2 motor, comprising KIF3A, KIF3B/C and KAP3, toward the neuromuscular junction where ACh functions as a neurotransmitter. ACh is
released into the synaptic cleft upon stimulation and rapidly degraded into choline and acetic acid by AChE. Choline is taken up into the nerve terminalb y
choline transporters and then ChAT synthesizes ACh from choline and acetyl-CoA. The reaction catalized by ChAT is the rate-limiting step for ACh supply
to the nerve terminals. In motor neurons expressing mutant SOD1 (B), mutant SOD1 proteins were converted into misfolded forms as a result of increased
ROS generation and/or reduced proteasomal activity. Certain misfolded species preferentially binds to KAP3 and inhibit the binding of ChAT to KAP3,
thereby causing a decrease in ChAT transport. This decrease in ChAT in the nerve terminals can constitute a mechanism that causes motor dysfunction.
Human Molecular Genetics, 2009, Vol. 18, No. 5 951A recent study provides an interesting evidence that tran-
scription of all members of the KIF3 family selectively
decreases in motor cortex of sporadic ALS patients among
13 kinds of kinesin and kinesin-related proteins (37). Impaired
neuromuscular transmission was detected in early sporadic
ALS patients (38), and a reduced supply of releasable ACh
was thought to be the primary cause for the degeneration of
motor terminal in a dog model of hereditary spinal muscular
atrophy (30,39). It is possible that kinesin-2 dysfunction and
subsequent inhibition of ChAT transport might be one of the
common pathways leading to motor neuron-speciﬁc dysfunc-
tion in both sporadic and familial ALS cases.
The cargos and adaptor molecules for kinesin-2 have not
been well studied. Small GTP-binding protein dissociation
factor SmgGDS (40), fodrin (41), a tumor suppressor adeno-
matous polyposis coli (42), N-cadherin (43), ChAT and
AChE (18) have been reported as molecules that bind to
KAP3. Our ﬁnding that misfolded SOD1 species sequesters
KAP3 raises a possibility that the transport of these molecules
may also be impaired in mutant SOD1-related FALS, together
with the reduced ChAT transport. Indeed, we observed a slight
decrease in N-cadherin transport in motor axons from pre-
symptomatic SOD1
G93A-Tg mice (Supplementary Material,
Fig. S5). The expression and function of those molecules
within motor neurons need to be studied to elucidate the
entire mechanism.
MATERIALS AND METHODS
All the data in Figures 1–6 are a representative of three mice
per group or three independent experiments. Statistical signiﬁ-
cance was assessed by ANOVA followed by Fisher’s test.
Error bars in graphs represent standard deviations. Signals in
immunoblots were detected using ECL (GE Healthcare) and
quantiﬁed with NIH image software (1.61J).
Reagents
All four types (WT, G93A, G85R and A4V) of FLAG-tagged
human SOD1 cDNA at the C terminus were cloned into
pcDNA3 (44). Full-length mouse (Image clone ID: 5698182)
and human (4829354) KAP3 were purchased from Image
clone bank and cloned into pcDNA3 and pCMV-Tag1,
respectively. The integrity of each clone was veriﬁed by
nucleotide sequence analysis. The siRNA designed for silen-
cing mouse KAP3 (M-047278-00-0010) was purchased from
Dharmacon Research. Primary antibodies used for immuno-
blots were as follows: anti-SOD1 (Stressgen, SOD-100, and
Calbiochem, 574597), kinesin C2 (Afﬁnity BioReagents) and
CRMP-2 (Immuno-Biological Laboratories). Anti-ChAT
(AB144P), KHC (MAB1614), KLC (MAB1617), synaptophy-
sin (MAB5258-20UG), actin (MAB1501), Neuroﬁlament-M
(AB1987) and MBP (myelin basic protein, AB9046) anti-
bodies were all purchased from Chemicon. Anti-KAP3,
KIF3A, KIF3B, p150
Glued, p50 dynamitin, dynein IC, KIF2
and Rab3 antibodies were purchased from BD PharMingen/
Transduction Laboratories. Primary antibodies used for immu-
noprecipitation and immunostaining were anti-SOD1 (Stress-
gen, SOD-100), ChAT (Chemicon, AB144P) and FLAG
(Sigma, F3165) antibodies. KAP3 antibody was prepared by
immunizing rabbits with a peptide containing the 1–14
amino acids of mouse KAP3, which are conserved in human
KAP3, followed by afﬁnity puriﬁcation using an epitope-
conjugated column.
Animals
We used the G1L line of transgenic mice harboring the
G93A-mutated human SOD1 gene (B6SJL-TgN(SOD1-
G93A)1Gur
dl) purchased from the Jackson Laboratories.
Mice harboring wild-type human SOD1 gene (B6.Cg-Tg
(SOD1)2Gur/J) was a gift from Dr Kawamata of Kyoto Uni-
versity. C57BL/6J mice were also used. The transgenic mice
were backcrossed with C57BL/6J for more than 14 gener-
ations. All data were derived from male mice. All the
animal experiments were approved by the Animal Care
Committee of National Center of Neurology and Psychiatry
(NCNP).
Preparation of subsegments from mouse spinal
cords using LMD technique
Frozen sections from mouse spinal cords were prepared
without ﬁxation and processed through AS LMD (Leica) as
previously described (17). Five sections were pooled for
each sample location for subsequent analyses.
Isolation of misfolded SOD1 species from ventral
white matter of spinal cords
The spinal cord was dissected from the indicated mice, and the
ventral half of white matter at L1-S3 level was carefully dis-
sected under a microscope. The dissected samples were homo-
genized in 300 ml of Nz homogenization buffer [20 mM
HEPES, pH 7.4, 120 mM NaCl, 2 mM EDTA, pH 8.0, 0.25%
NP-40 and complete protease inhibitor cocktail (Roche)] fol-
lowed by a brief sonication., The lysates were added to
3.2 ml of Nycodenz linear density gradient in 10 mM
HEPES, pH 7.4 and 1 mM EDTA, pH 8.0 (initial concentration
of Nycodenz was 30%). After a centrifugation at 87 479g for
2 h at 48C, in Optima MAX-E using MLS 50 rotor (Beckman
Coulter), 160 ml of aliquot was collected from the top to the
bottom of the tube, totaling 22 fractions. Twenty microliters
of each fraction was collected and analyzed by immunoblot.
Immunoprecipitation
Afﬁnity-puriﬁed anti-KAP3 and anti-SOD1 antibodies were
captured with Dynabeads Protein G (Dynal Biotech) and
cross-linked using dimethyl pimelimidate as per manufac-
turer’s protocol. For the immunoprecipitation from fractions
prepared from Nycodenz density gradient centrifugation,
30 ml of each fraction was mixed with the antibody-
conjugated Dynabeads in 20 mM HEPES, pH 7.4, 120 mM
NaCl, 2 mM EDTA and complete protease inhibitor cocktail.
The mixture was incubated overnight at 48C on a rocking plat-
form, followed by washing with PBS containing 0.05%
Tween-20. The target proteins were eluted with 30 mlo f
0.1 M citric acid (pH 2.0) for 2 min, and half of the eluates
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or SOD1-transfected PNG3 cells, tissues or cells were lysed in
TN-T buffer (50 mM Tris–HCl, pH 7.6, 1% Triton X-100,
150 mM NaCl) containing complete protease inhibitor cocktail
and subjected to a centrifugation at 5000g for 10 min at 48C.
The supernatants were incubated with antibody-conjugated
Protein G Dynabeads and analyzed as described above.
Preparation of transported components
from ventral cauda equina
The fraction enriched with transported components within
motor axons was prepared from ventral roots of caudal
spinal cords as described (41) with the following modiﬁ-
cations. Ventral cauda equina was minced for two times in
400 ml of IM-D buffer supplemented with 1 mM ATP and a
protease inhibitor cocktail (Complete; Roche) for 10 min on
ice. They were subsequently subjected to centrifugation at
5000g for 10 min at 48C. The obtained supernatants were
measured for protein concentration and 5 mg of each was sub-
jected to SDS/PAGE to evaluate the kinesin-2 contents. To
analyze kinesin-2 status, the transported vesicle fractions pre-
pared from four mice were subjected to 4.4 ml of sucrose step
gradient centrifugation ranging from 0.2 to 2%. After centrifu-
gation in an SW55 Ti rotor (Beckman Coulter) at 50 000 rpm
for 18 h at 48C, 400 ml of each fraction was collected from top
of the tube, totaling 12 fractions, and 20 ml of each fraction
was analyzed by SDS–PAGE/immunoblots.
Cell culture and transfection
NG108-15cells(akindgiftfromDrAkazawainTokyoMedical
and Dental University), a hybrid cell line of mouse N18TG2
neuroblastoma cells and rat C6-BU-1 glioma cells, were cul-
tured in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
(Sigma, D5796) containing 10% fetal bovine serum and 2%
HAT supplement (GIBCO). Differentiation of PNG3, a sub-
clone of NG108-15 isolated from single cells, was induced
with 1 mM of dibutyryl cAMP (Nacalai tesque) and 0.2 mM of
dexamethasone (MB Biomedicals) for 3 days. Transfection of
plasmidsintoPNG3wasperformedusingOptifectorLipofecta-
mine2000(InvitrogenLifeTechnologies)aspermanufacturer’s
protocol. Culture medium was changed every 20–24 h except
where indicated otherwise. Transfection of siRNA and
co-transfectionofsiRNAwithplasmidswereperformedaccord-
ing to the manufacturer’s protocols using DharmaFECT trans-
fection reagent 2 (Dharmacon) and DharmaEFCT Duo
transfection reagent, respectively. For induction of SOD1 mis-
folding/aggregation, cells were treated with 6.5 mM of MG132
(a proteasome inhibitor) 56 h after transfection and then treated
with 2.5 mM hydrogen peroxide for 2 h at 72 h after transfec-
tion. Cells were then lysed with TN-T buffer plus Complete
protease inhibitor cocktail and subjected to centrifugation at
10 000g for 10 min at 48C to be separated into soluble (super-
natant) and insoluble (pellet) fractions.
Measurement of [
3H]ACh release
Depolarization-induced [
3H]ACh release was measured based
on the method previously described (Kumagai et al., 1993)
with several modiﬁcations. For metabolic labeling of PNG3
cells by [
3H]choline, DMEM lacking choline chloride was
used. Time schedules for labeling, reagents used and incu-
bation time are shown in Figure 6C.
The culture medium was changed to choline-free DMEM
either with or without colchicine. After 2 h incubation,
6.25 kBq [
3H]choline chloride ([methyl-
3H] choline chloride,
2.2 TBq/mmol; GE Healthcare) was added to the medium of
each well of a 12-well plate. After 2 h incubation, the
medium was changed to ACh release measuring buffer
[20 mM HEPES-NaOH, pH 7.4, 150 mM NaCl, 5 mM KCl,
1.8 mM CaCl2, 0.8 mM MgSO4,2 5 m M glucose, 25 mM
eserine sulfate and 10 mM hemicholinium-3 (HC-3)] and the
culture plates were returned to the CO2 incubator. Eserine,
an inhibitor for cholinesterase, was added to inhibit a degra-
dation of released ACh by cholinesterase. HC-3, an inhibitor
for high-afﬁnity choline transporter 1, was added to comple-
tely inhibit [
3H]choline uptake after changing the medium.
After 15 min incubation, with eserine and HC-3, an aliquot
of culture medium was transferred into a 1.5 ml tube (media
before KCl addition), and then KCl was added into the
medium to a ﬁnal concentration of 50 mM. The culture
plates were quickly returned to the CO2 incubator, and after
15 min, the medium was transferred into a new 1.5 ml tube
(media after KCl addition). Both the medium collected
before and after KCl addition were centrifuged at 10 000g
for 5 min at 48C to remove debris. The supernatants were
mixed with a scintillation cocktail (Ultima Gold XR, Perkin
Elmer) to measure the [
3H] radioactivity using a liquid scintil-
lation spectrophotometer. The radioactivity of [
3H]ACh
released by KCl was calculated by subtracting the activity of
media before KCl (¼S1) from the activity of media after
KCl addition (¼S2), as described in Figure 6C.
Immunocytochemistry
PNG3 cells were ﬁxed with 4% paraformaldehyde in PBS for
15 min. After permeabilization with 0.15% Triton X-100 in
PBS for 10 min, cells were treated with Blocking-one
(Nacalai) for 1 h. The cells were then treated with primary
antibodies in Blocking-one at 48C overnight. The cells were
washed with PBS. For detection, cells were treated with
ﬂuorescent-conjugated secondary antibodies in Blocking-one
at room temperature for 1 h. After washing again with PBS,
cells were mounted with Vectasheld (Vector Laboratories).
Autopsy specimens and immunohistochemistry
The studies were performed on archival, buffered 10%
formalin-ﬁxed, parafﬁn-embedded spinal cord tissues obtained
at autopsy from four FALS patients who were members of two
different families. Consent for autopsy was obtained from
legal representatives in accordance with the requirements of
local institutional review boards. The clinicopathological
characteristics of the FALS patients have been previously
reported (27,29). SOD1 gene analysis revealed that the
members of the Japanese Oki family had a 2 bp deletion at
codon 126 in the gene for SOD1 (frame-shift 126 mutation,
D125X) and that the members of the T family had a
Leucine to Valine substitution at codon 106 in the SOD1
Human Molecular Genetics, 2009, Vol. 18, No. 5 953gene (L106V). To look at the expression of KAP3 and SOD1
in these specimens, afﬁnity-puriﬁed rabbit anti-KAP3 anti-
body (0.05 mg/ml, diluted 1:200 in 1% bovine serum albumin-
containing PBS, pH 7.4), mouse monoclonal antibody against
human SOD1 (0.5 mg/ml, clone1G2, MBL, Aichi, Japan) and
sheep polyclonal antibody against human SOD1 (1:20,000,
Calbiochem, Darmstadt, Germany) were used as primary anti-
bodies. Immunohistochemical reaction was performed by a
standard procedure. Antibody signal was visualized by the
avidin–biotin–immunoperoxidase complex (ABC) method
using the appropriate Vectastain ABC Kit (Vector Labora-
tories, Burlingame, CA, USA) and 3,30-diaminobenzidine tet-
rahydrochloride (DAB; Dako, Glostrup, Denmark) as the
chromogen.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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